Eva Dahlén is a life science professional with over 15 years of experience from the life science sector, including business development, project and team management and several scientist positions. Eva has a strong scientific background within immunology and oncology. She holds a PhD in immunology from Lund university, Sweden, and is specialized in immunotherapy of cancer.
Eva’s current role is as Senior Director, Business Development at Alligator Bioscience. In this capacity, she establishes and maintains collaborations with pharma and biotech companies as well as with academic institutions. She is responsible for the scientific business development, structuring and negotiating partnership agreements and for competitive intelligence and business strategies within the organization. Prior to assuming this position, she held various scientist positions, the most recent being as principal scientist and project leader for development of innovative tumor-directed immunotherapies.